Navigation Links
Coronary heart disease bids Adieu

According to a report in The Journal of the American Medical Association. Coronary heart disease is reduced by lowering plasma homocystine levels with a diet supplement of folic acid alone or in combination with cyanocobalamin.

Dr.Tice from the University of California at San Francisco and colleagues used the Coronary Heart Disease Policy Model to assess the cost effectiveness of lowering levels of homocystine through grains fortified with folic acid and with cyanocobalamin and folic acid among participants in the third National Health and Nutrition Examination Survey.//

Their model predicted that grains fortified with folic acid could reduce myocardial infarction by 13% in men and 8% in women, with comparable reductions in death from CHD. "Using our most conservative assumptions, the estimated reductions in annual CHD mortality rates were 1% to 3%," the researchers report.

In addition to consuming fortified grains, if all patients with CHD received 1 mg of folic acid plus 0.5 mg of cyanocobalamin per day, the model projected that there would be approximately 310,000 fewer deaths and lower CHD-related costs over 10 years, compared with consuming folic-acid-fortified grains alone.

Over the same 10-year period, the model also predicted that for men 45 years of age or older without CHD, folic acid and cyanocobalamin supplementation given in addition to fortified grains would save more than 300,000 quality adjusted life-years. In addition, for women 55 years of age and older without CHD, the same strategy would result in 140,000 quality adjusted life-years saved, Dr.Tice's group calculated.


Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Coronary stent leads to complications
3. Older Men Surviving Coronary Bypasses
4. The Link Between Oxidized Phospholipids And Coronary Artery Disease
5. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
6. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Children Are At The Risk Of Inheriting Coronary Disease
9. Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival
10. Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease
11. Microcirculation in Eye May Indicate Coronary Heart Death Risk
Post Your Comments:

(Date:12/1/2015)... ... 2015 , ... With FCPX Overlay: Grit , users can apply a ... possibilities are truly endless, all with a click of a mouse. Each user has ... flip, depth of field and more, all within Final Cut Pro X. , With ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ... and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact ...
(Date:11/30/2015)... Turks & Caicos Islands, BWI (PRWEB) , ... December 01, 2015 ... ... in 2015. Recently Caribbean Journal, one of the leading digital news sites highlighting ... The top reason? The weather. While much of North America shivers under chilly ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... the19th Bi-National Convention of the Federation of Philippine American Chambers of Commerce held ... Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate from the ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (Meso Foundation) released information for caregivers and held two webinars on topics of ... on demand free of charge at . , With a loved ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  The fee-for-service reimbursement ... U.S. medical imaging is on its way ... care payer-provider contracts are set to phase ... wake, alter provider-vendor relationships. The shift to ... forward new purchasing frameworks in the medical ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
(Date:11/30/2015)... and ST. LOUIS , Nov. ... (NASDAQ: ESRX ) today announced an early renewal ... which began in 1999, will now extend through at ... --> After evaluating pharmacy benefit manager capabilities during ... Express Scripts continues to offer the best health plan ...
Breaking Medicine Technology: